H.R. 2520 (109th): Stem Cell Therapeutic and Research Act of 2005

Introduced:

May 23, 2005
109th Congress, 2005–2006

Status:

Enacted — Signed by the President on Dec 20, 2005

This bill was enacted after being signed by the President on December 20, 2005.

Law:

Pub.L. 109-129

Sponsor:

Christopher “Chris” Smith

Representative for New Jersey's 4th congressional district

Republican

Text:

Read Text »
Last Updated: Dec 19, 2005
Length: 14 pages

About the bill

Full Title

To provide for the collection and maintenance of human cord blood stem cells for the treatment of patients and research, and to amend the Public Health Service Act to authorize the C.W. Bill Young Cell Transplantation Program.

Read CRS summary >

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

S. 1317 (identical)

Reported by Committee
Last Action: Jun 29, 2005

What is a bill?

The “H.R.” in “H.R. 2520” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

History

Introduced
May 23, 2005
Passed House
May 24, 2005
View Vote Result »
Passed Senate with Changes
Dec 16, 2005
Vote was by Unanimous Consent so no record of individual votes was made.
House Agreed to Changes
Dec 17, 2005
View Vote Result »
Enacted — Signed by the President
Dec 20, 2005

Details

Cosponsors
78 cosponsors (65R, 13D) (show)
Committee Assignments
Health

The committee chair determines whether a bill will move past the committee stage.

Votes
On Motion to Suspend the Rules and Pass
May 24, 2005 6:17 p.m.
Passed 431/1

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Citation

Click a format for a citation suggestion: